Prelude Therapeutics Inc (PRLD)
4.25
-0.62
(-12.73%)
USD |
NASDAQ |
Apr 17, 15:18
Prelude Therapeutics Price to Book Value: 0.9845 for April 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 16, 2024 | 1.128 |
April 15, 2024 | 1.304 |
April 12, 2024 | 1.302 |
April 11, 2024 | 1.209 |
April 10, 2024 | 1.147 |
April 09, 2024 | 1.156 |
April 08, 2024 | 1.089 |
April 05, 2024 | 1.089 |
April 04, 2024 | 1.098 |
April 03, 2024 | 1.093 |
April 02, 2024 | 1.070 |
April 01, 2024 | 1.086 |
March 28, 2024 | 1.098 |
March 27, 2024 | 1.105 |
March 26, 2024 | 1.068 |
March 25, 2024 | 1.068 |
March 22, 2024 | 1.089 |
March 21, 2024 | 1.116 |
March 20, 2024 | 1.121 |
March 19, 2024 | 1.121 |
March 18, 2024 | 1.077 |
March 15, 2024 | 1.098 |
March 14, 2024 | 1.033 |
March 13, 2024 | 1.070 |
March 12, 2024 | 0.9497 |
Date | Value |
---|---|
March 11, 2024 | 0.9474 |
March 08, 2024 | 1.024 |
March 07, 2024 | 1.015 |
March 06, 2024 | 0.966 |
March 05, 2024 | 0.9613 |
March 04, 2024 | 0.9845 |
March 01, 2024 | 1.063 |
February 29, 2024 | 0.9961 |
February 28, 2024 | 0.966 |
February 27, 2024 | 0.9706 |
February 26, 2024 | 0.9474 |
February 23, 2024 | 0.9173 |
February 22, 2024 | 0.8965 |
February 21, 2024 | 0.8756 |
February 20, 2024 | 0.9636 |
February 16, 2024 | 1.072 |
February 15, 2024 | 0.8061 |
February 14, 2024 | 0.783 |
February 13, 2024 | 0.7227 |
February 12, 2024 | 0.7459 |
February 09, 2024 | 0.7088 |
February 08, 2024 | 0.6208 |
February 07, 2024 | 0.681 |
February 06, 2024 | 0.6764 |
February 05, 2024 | 0.6764 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3889
Minimum
Oct 31 2023
20.13
Maximum
Feb 10 2021
3.284
Average
1.564
Median
Price to Book Value Benchmarks
CEL-SCI Corp | 6.614 |
AIM ImmunoTech Inc | 2.582 |
IGC Pharma Inc | 4.224 |
NovaBay Pharmaceuticals Inc | 1.838 |
Protalix BioTherapeutics Inc | 2.492 |
Price to Book Value Related Metrics
Price | 4.25 |
Earnings Yield | -48.00% |
Market Cap | 233.41M |